BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24825325)

  • 1. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
    Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
    Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
    J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT
    Su H; Xu X; Yan C; Shi Y; Hu Y; Dong L; Ying S; Ying K; Zhang R
    Respir Res; 2018 Dec; 19(1):254. PubMed ID: 30547791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.
    Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
    Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
    Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Yamamura A; Nayeem MJ; Sato M
    Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model.
    Fan Y; Hao Y; Gao D; Li G; Zhang Z
    Physiol Res; 2021 Apr; 70(2):213-226. PubMed ID: 33676385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
    Hudalla H; Michael Z; Christodoulou N; Willis GR; Fernandez-Gonzalez A; Filatava EJ; Dieffenbach P; Fredenburgh LE; Stearman RS; Geraci MW; Kourembanas S; Christou H
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):512-524. PubMed ID: 30951642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFκB pathway in pulmonary arterial hypertension.
    Yan X; Huang J; Zeng Y; Zhong X; Fu Y; Xiao H; Wang X; Lian H; Luo H; Li D; Guo R
    Biochem Pharmacol; 2024 Apr; 222():116093. PubMed ID: 38408681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells.
    Gao L; Fan Y; Hao Y; Yuan P; Liu D; Jing Z; Zhang Z
    Int J Med Sci; 2017; 14(9):820-828. PubMed ID: 28824319
    [No Abstract]   [Full Text] [Related]  

  • 15. Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1α and Runx2.
    Chi PL; Cheng CC; Wang MT; Liao JB; Kuo SH; Lin KC; Shen MC; Huang WC
    Cardiovasc Res; 2024 Mar; 120(2):203-214. PubMed ID: 38252891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
    Liu C; Wan N; Wei L; Rong W; Zhu W; Xie M; Zhang Y; Liu Z; Jing Q; Lyu A
    Vascul Pharmacol; 2023 Dec; 153():107233. PubMed ID: 37742818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
    Chen YJ; Li HF; Zhao FR; Yu M; Pan SY; Sun WZ; Yin YY; Zhu TT
    Int Immunopharmacol; 2024 May; 132():111946. PubMed ID: 38552292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration.
    Pullamsetti S; Krick S; Yilmaz H; Ghofrani HA; Schudt C; Weissmann N; Fuchs B; Seeger W; Grimminger F; Schermuly RT
    Respir Res; 2005 Nov; 6(1):128. PubMed ID: 16262900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGK1 mediates hypotonic challenge-induced proliferation in basilar artery smooth muscle cells via promoting CREB signaling pathway.
    Chen BY; Wang SR; Lu FT; Lv XF; Chen Y; Ma MM; Guan YY
    Eur J Pharmacol; 2021 May; 898():173997. PubMed ID: 33676941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of CaMKII/HDAC4 by SDF1 contributes to pulmonary arterial hypertension via stabilization Runx2.
    Chen Y; Liu J; Zhang Q; Chai L; Chen H; Li D; Wang Y; Qiu Y; Shen N; Zhang J; Wang Q; Wang J; Xie X; Li S; Li M
    Eur J Pharmacol; 2024 May; 970():176483. PubMed ID: 38479721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.